Patents by Inventor Kjell Morten Varum

Kjell Morten Varum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150126619
    Abstract: A process for the formation of an ionic gel comprising contacting a first polyelectrolyte reactant having a backbone comprising a plurality of ?-1,4-glycosidic linkages in the 4C1 conformation and an oligoelectrolyte reactant or second polyelectrolyte reactant, having a backbone containing a plurality of ?-1,4-glycosidic linkages in the 4C1 conformation, in aqueous solution under pH conditions such that one reactant is charged and the other uncharged; adding a donor to adjust the pH such that said uncharged reactant possesses a charge opposite to that of the charged reactant so as to form an ionic gel.
    Type: Application
    Filed: September 14, 2012
    Publication date: May 7, 2015
    Applicant: NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (NTNU)
    Inventors: Kjell Morten Varum, Kurt Ingar Draget
  • Patent number: 7875449
    Abstract: Low molecular weight low molecular weight chitosan oligomers were able to self-assemble siRNA into nanosized particles, provide protection against enzymatic degradation, and mediate gene silencing that is stable over a long period of time in vitro. The control of structural variables in formulating complexes of siRNA with low molecular weight chitosans provides an efficient alternative delivery system for siRNA in vitro and in vivo.
    Type: Grant
    Filed: September 14, 2007
    Date of Patent: January 25, 2011
    Assignee: FMC Biopolymer AS
    Inventors: Per Artur Sven Artursson, Mohamed Mahmoud Issa, Sabina Prochazkova Strand, Kjell Morten Varum
  • Publication number: 20080131371
    Abstract: Low molecular weight low molecular weight chitosan oligomers were able to self-assemble siRNA into nanosized particles, provide protection against enzymatic degradation, and mediate gene silencing that is stable over a long period of time in vitro. The control of structural variables in formulating complexes of siRNA with low molecular weight chitosans provides an efficient alternative delivery system for siRNA in vitro and in vivo.
    Type: Application
    Filed: September 14, 2007
    Publication date: June 5, 2008
    Applicant: FMC BIOPOLYMER AS
    Inventors: Per Artur Sven Artursson, Mohamed Mahmoud Issa, Sabina Prochazkova Strand, Kjell Morten Varum
  • Publication number: 20040215005
    Abstract: The invention provides a process for the preparation of chitosan which process comprises swelling particulate chitin with an aqueous solution for a period of at least 36 hours, and subsequently reacting the resultant swollen particulate chitin with an alkaline solution at an elevated temperature whereby to cause a deacetylation to occur.
    Type: Application
    Filed: June 15, 2004
    Publication date: October 28, 2004
    Inventors: Kjell Morten Varum, Olav Smidsrod